Tenon Medical (TNON) Cost of Revenue (2021 - 2026)

Tenon Medical's Cost of Revenue history runs 6 years deep, the most recent figure standing at $434000.0 for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 7.69% year-over-year to $434000.0 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 5.99% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, up 1.28% from the prior year.
• Cost of Revenue declined to $434000.0 in Q1 2026 per TNON's latest filing, from $464000.0 in the prior quarter.
• Across five years, Cost of Revenue topped out at $549000.0 in Q2 2023 and bottomed at $249000.0 in Q4 2023.
• The 5-year median for Cost of Revenue is $409000.0 (2023), against an average of $388529.4.
• Across the five-year window, Cost of Revenue soared 2911.11% in 2022 and slumped 48.55% in 2023, its largest moves.
• Year by year, Cost of Revenue stood at $484000.0 in 2022, then slumped by 48.55% to $249000.0 in 2023, then jumped by 67.47% to $417000.0 in 2024, then increased by 11.27% to $464000.0 in 2025, then slipped by 6.47% to $434000.0 in 2026.
• Per Business Quant, the three latest TNON Cost of Revenue figures stand at $434000.0 (Q1 2026), $464000.0 (Q4 2025), and $400000.0 (Q3 2025).